Status:
COMPLETED
Incidence of Bacteremia Following Argon Plasma Coagulation in Patients With Endobronchial Lesions
Lead Sponsor:
Meir Medical Center
Conditions:
Bacteremia
Eligibility:
All Genders
18+ years
Brief Summary
Incidence of Bacteremia Following Argon Plasma Coagulation in Patients with Endobronchial Lesions
Detailed Description
Bacteremia is a well-recognized invasive medical condition. In most cases, it is a transient phenomenon without clinical consequences. In certain patients, such as those with structural cardiac abnorm...
Eligibility Criteria
Inclusion
- All patients that undergo bronchoscopy with the use of APC
Exclusion
- All patients under 18 years old All Patients with evidence of current respiratory infection or febrile illnesses and those that will receive antibiotic therapy within a week prior to the bronchoscopy
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT01179022
Start Date
October 1 2010
End Date
October 1 2012
Last Update
March 13 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir MC
Kfar Saba, Israel, Israel, 49100